Yoshihiro Sakoda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yoshihiro sakoda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yoshihiro Sakoda Today - Breaking & Trending Today

Infected migratory birds began arriving in Japan by late September, the earliest on record. They have reached various locations around Japan, spreading the virus on an unprecedented scale.

Hokkaido University avian flu expert Professor Yoshihiro Sakoda. Japan has seen an unusually high number of avian influenza outbreaks this season, raising fears that the number of birds culled to prevent the disease from spreading could hit a record high for a single season. ....

Yoshihiro Sakoda , Hokkaido University , Professor Yoshihiro ,

Bird flu forces culling of record 9.9 million chickens and ducks in Japan


Bird flu forces culling of record 9.9 million chickens and ducks in Japan
Sorry, but your browser needs Javascript to use this site.
If you re not sure how to activate it, please refer to this site: https://www.enable-javascript.com/
The number of chickens and ducks culled this season due to an outbreak of bird flu in Japan has hit a record high 9.87 million. | KYODO
Jiji
May 9, 2021
The outbreak of highly pathogenic avian influenza in Japan has almost ended after having swept across the country from last November.
This season, bird flu was discovered in 18 prefectures, including Chiba and Ibaraki, which are known for poultry farming. ....

Yoshihiro Sakoda , Maja Co , Hokkaido University , Eurasian Continent , Bird Flu , ோக்கைடோ பல்கலைக்கழகம் , யூரேசியன் கண்டம் ,

Tracing and controlling High Pathogenicity Avian Influenza


Date Time
Tracing and controlling High Pathogenicity Avian Influenza
Scientists have discovered a route of introduction for High Pathogenicity Avian Influenza Virus (HPAIV) H5N8 into Japan and, in parallel, have investigated the potential of two human anti-influenza drugs for the control of HPAI in birds.
The Northern Pintail, a migratory duck, one of which carried the High Pathogenicity Avian Influenza Virus H5N8 to Japan (Photo: Kohei Ogasawara).
Since October 30, 2020, there have been over 30 recorded outbreaks of High Pathogenicity Avian Influenza (HPAI) in domestic poultry and wild fowl in Japan. This outbreak was caused by the influenza A virus H5N8, a known High Pathogenicity Avian Influenza Virus (HPAIV). In such a scenario, identification of the source of the virus and its transmission route is important to control its spread. ....

Augustin Twabela , Baloxavir Marboxil , Norikazu Isoda , Kohei Ogasawara , Yoshihiro Sakoda , Japan International Cooperation Agency , Environment Research , Technology Research Partnership For Sustainable Development , Agency For Medical Research , Japan Agency For Medical Research , Technology Development , Hokkaido University , High Pathogenicity Avian Influenza Virus , Northern Pintail , High Pathogenicity Avian Influenza , Professor Yoshihiro Sakoda , Lake Komuke , East Asia , Eastern Asia , Pathogenicity Avian Influenza Virus Clade , Japan Initiative , Global Research Network , Infectious Diseases , Japan Agency , Medical Research , Technology Research Partnership ,

Industry-academia collaboration to fight flu and emerging infections


Hokkaido University
Development of anti-influenza drugs
Sato is a virus specialist with more than 40 years of experience. When he first took up the subject upon joining Shionogi, however, research on drugs to treat viral diseases was not receiving the kind of attention it deserved. In 1974, the world’s first anti-viral drug, Acyclovir, was developed in the United States, but it was not until the discovery of human immunodeficiency virus (HIV) and the development of genetic engineering in the 1980s that research on anti-viral drugs accelerated.
After devoting much of his time at Shionogi to researching HIV/AIDS (acquired immune deficiency syndrome) drugs, Sato was assigned to the development of drugs to treat influenza, which is estimated by the World Health Organization (WHO) to cause about 3 million to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths annually worldwide. Hokkaido University was an ideal institution for Shionogi to co ....

United States , Hiroshi Kida , Yoshihiro Sakoda , Biocryst Pharmaceuticals , Shionogi Innovation Center , World Health Organization , Research Center , Hokkaido University , Zoonosis Control , Drug Discovery , ஒன்றுபட்டது மாநிலங்களில் , ஹிரோஷி கீத , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆராய்ச்சி மையம் , ோக்கைடோ பல்கலைக்கழகம் , மருந்து கண்டுபிடிப்பு ,